On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Eisai Cuts Leqembi Sales Target as It Sees “Some Delays” in US Uptake
November 11, 2024
-
ACADEMIA Private-Academia Collab Yields 8 Pediatric Drug Approvals in Japan
November 8, 2024
-
REGULATORY Chuikyo Supports Full Rollout of Company Indices for Generics Manufacturers
November 7, 2024
-
BUSINESS Nxera Pharma Eyes 50 Billion Yen in Global Revenue by 2030: CEO
November 7, 2024
-
ACADEMIA Alzheimer’s-Related Guidelines Being Revised to Accommodate Kisunla, Rexulti
November 6, 2024
-
ACADEMIA Japan Crafting Registry of All Hemophilia Patients, Company Use Eyed Too
November 5, 2024
-
REGULATORY Advisory Panel Backs Transfer of GMP Inspection Authority for New Generics to PMDA
November 5, 2024
-
REGULATORY PMDA Opens US Office in Washington, D.C.
November 5, 2024
-
BUSINESS FDA Rolling Submission for Leqembi SC Completed: Eisai
November 5, 2024
-
BUSINESS Kyowa Kirin Picks Abdul Mullick as New President and COO
November 1, 2024
-
BUSINESS Otsuka Holdings Names Makoto Inoue as New CEO
November 1, 2024
-
REGULATORY BeiGene’s Brukinsa, J&J’s Balversa and More Now in Line for Japan Approval
October 31, 2024
-
BUSINESS 604 Employees Raise Hands for Sumitomo’s Buyout Program
October 31, 2024
-
ACADEMIA 50% of Quit-Smoking Clinics Closed or Suspended, Will Champix Re-Supply Bring Them Back Online?
October 30, 2024
-
REGULATORY Ruling Bloc’s Loss of Lower House Majority Might Sway Off-Year Revision Debates
October 29, 2024
-
REGULATORY LDP Loses Big in Snap Election, Many Health-Savvy Members Ousted
October 28, 2024
-
BUSINESS AbbVie Taps Tiago Campos Rodrigues as Japan President
October 28, 2024
-
BUSINESS Recordati to Enter Japan’s Hematology/Oncology Market with Enjaymo Acquisition
October 25, 2024
-
BUSINESS NHI-Market Price Gap Expected to Contract in 2024, Will It Enter Lower 5% Territory?
October 24, 2024
-
BUSINESS CEA Is “Wrong Tool” That Doesn’t Fit into Japanese System: J&J Exec
October 23, 2024
ページ
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Japan will trim the NHI price of Eli Lilly Japan’s Alzheimer’s treatment Kisunla (donanemab) by 3.93% under the cost-effectiveness assessment…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
As Japan’s budget season draws near, the Ministry of Finance (MOF) has renewed its push for a full-scale “off-year” drug…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…